Скачать или смотреть Can Cell-Based Innovation Keep Humanity in Peak Condition?

The paradigm of medicine is shifting from treating disease with external chemistry to engineering biology itself, using programmable cells as "living therapies" to repair, regenerate, and even enhance the human body. This is no longer a theoretical frontier: by January 2025, 72 non-genetically modified cell therapies were already approved for clinical use, with a remarkable 58% of new trials now targeting non-cancer conditions.

With this technology rapidly moving into the mainstream, will it truly democratize "peak condition" for the many, or will its power to enhance the human body create the ultimate biological divide between the treated and the untreated?

Speakers:
• Hans Keirstead, Ph.D., Chairman, Immunis, Inc.
• Dr. Ying Lee, Founder & Managing Partner, Atma Capital
• Alex Zhavoronkov, Ph.D., Founder, CEO & CBO, Insilico Medicine

Moderator:
• Christian Egle, EMEIA Healthcare Leader, EY